Amarin | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.86B 306M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Amarin USD 36.9M 1.64M 2024-09
AstraZeneca USD 5.55B 307M 2024-12
DBV Technologies USD 6.24M 1.32M 2024-09
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12



Amarin 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.